Cognition Therapeutics, Inc.
USD1.13
+0.04 (+3.65%)
CEO
Lisa Ricciardi
IPO Date
2021-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.10
Prev. Close
$1.09
Day Low
$1.10
Day High
$1.16
52W Low
$0.29
52W High
$3.83
Market Cap
$0.08B
Volume
0.26M
| 25,000 |
| $0.00 |
| 22 Jun 2026 | Wallace Peggy | director | A-Award | Acquired | 25,000 | $0.00 |
| 22 Jun 2026 | RICHSTONE ELLEN B | director | A-Award | Acquired | 25,000 | $0.00 |
| 22 Jun 2026 | Fletcher Aaron G.L. | director, 10 percent owner: | A-Award | Acquired | 25,000 | $0.00 |
| 4 May 2026 | Doyle John Brendan | Chief Financial Officer | F-InKind | Disposed | 8,567 | $1.28 |
| 20 Apr 2026 | Doyle John Brendan | Chief Financial Officer | P-Purchase | Acquired | 10,000 | $1.13 |
| 20 Apr 2026 | Ricciardi Lisa | director, officer: CEO & President | P-Purchase | Acquired | 9,175 | $1.10 |
| 20 Apr 2026 | Caggiano Anthony | Chief Medical Officer | P-Purchase | Acquired | 10,000 | $1.11 |
| 18 Feb 2026 | Ricciardi Lisa | director, officer: CEO & President | F-InKind | Disposed | 5,850 | $1.12 |